Comparison of the Amplicor HIV-1 Monitor test and the nucleic acid sequence-based amplification assay for quantitation of human immunodeficiency virus RNA in plasma, serum, and plasma subjected to freeze-thaw cycles

Journal of Clinical Microbiology

Volumn 35, Issue 12, 1997, Pages 3288-3291

  Griffith, Brigitte P ^a,b   Rigsby, Michael O ^a,b   Garner, Robin B ^b   Gordon, Monica M ^b   Chacko, Thomas M ^a  

^a VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; NUCLEIC ACID; VIRUS RNA;

ARTICLE; FREEZING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; NUCLEOTIDE SEQUENCE; PLASMA; PRIORITY JOURNAL; SERUM; THAWING;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0030711103     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.35.12.3288-3291.1997     Document Type: Article

References (19)

1. Boom, R., C. J. A. Sol, J. Van Der Noordaa, C. L. Jansen, P. M. E. Werheim-Van Dillen, and J. Van Der Noordaa. 1990. Rapid and simple method for purification of nucleic acids. J. Clin. Microhiol. 28:495-503.
2. Coombs, R. W., D. R. Henrard, W. F. Mehaffey, J. Gibson, E. Eggert, T. C. Quinn, and J. Phillips. 1993. Cell-tree plasma human immunodeficiency virus type 1 titer assessed by culture and immunocapture-reverse transcription-polymerase chain reaction. J. Clin. Microbiol. 31:1980-1986.
3. Ho, D. D., A. U. Newmann, A. S. Perelson, W. Chen, J. M. Leonard, and M. Markowitz. 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373:123-126.
4. Holodniy, M., D. A. Katzenstein, S. Sengupta, A. M. Wang, C. Casipit, D. H. Schwartz, M. Konrad, E. Groves, and T. C. Merigan. 1991. Detection and quantification of human immunodeficiency virus RNA in patient serum by use of the polymerase chain reaction. J. Infect. Dis. 163:862-866.
5. Larder, B. A., S. D. Kemp, and P. R. Harrigan. 1996. Potential mechanism for sustained efficacy of AZT-3TC combination therapy. Science 269:696-699.
6. Lin, H. J., L. E. Myers, B. Yen-Lieberman, F. B. Hollinger, D. Henrard, C. J. Hooper, R. Kokka, S. Kwok, S. Rasheed, M. Vahey, M. A. Winters, L. J. McQuay, P. L. Nara, P. Reichelderfer, R. W. Coombs, and J. B. Jackson. 1994. Multicenter evaluation of quantification methods for plasma human immunodeficiency virus type 1 RNA. J. Infect. Dis. 170:553-562.
7. Mellors, J. W., L. A. Kingsley, C. R. Rinaldo, J. A. Todd, B. S. Hoo, R. P. Kokka, and P. Gupta. 1995. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann. Intern. Med. 122:573-579.
8. Mulder, J., N. McKinney, C. Christopherson, J. Sninsky, L. Greenfield, and S. Kwok. 1994. A rapid and simple PCR assay for quantitation of HIV-1 RNA in plasma: application to acute retroviral infection. J. Clin. Microbiol. 32:292-300.
9. + lymphocyte counts and the risk of progression to AIDS. N. Engl. J. Med. 334:426-431.
10. Piatak, M., M. S. Saag, L. C. Yang, S. J. Clark, J. C. Kappes, K. C. Luk, B. H. Hahn, G. M. Shaw, and J. D. Lifson. 1993. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 259: 1749-1754.
11. Revets, H., D. Marissens, S. De Wit, P. Lacor, N. Clumeck, S. Lauwers, and G. Zissis. 1996. Comparative evaluation of Nasba HIV-1 RNA QT, AMPLICOR-HIV Monitor, and QUANTIPLEX HIV RNA assay, three methods for quantification of human immunodeficiency virus type 1 RNA in plasma. J. Clin. Microbiol. 34:1058-1064.
12. Schuurman, R., D. Descamps, G. J. Weverling, S. Kaye, J. Tijnagel, I. Williams, R. Van Leeuwen, R. Tedder, C. A. B. Boucher, F. Brun-Vezinet, and C. Loveday. 1996. Multicentcr comparison of three commercial methods for the quantification of human immunodeficiency virus type 1 RNA in plasma. J. Clin. Microbiol. 34:3016-3022.
13. Schuurman, R., M. Nijhuis, R. Van Leeuwen, P. Schipper, D. De Jong, P. Collis, S. A. Donner, J. Mulder, C. Loveday, C. Christopherson, S. Kwok, J. Sninsky, and C. A. B. Boucher. 1995. Rapid changes in human immunodeficiency virus type 1 RNA load and appearance of drug-resistant virus populations in persons treated with lamivudine (3TC). J. Infect. Dis. 171:1411-1419.
14. Urdea. M. S. 1993. Synthesis and characterization of branched DNA (bDNA) for the direct and quantitative detection of CMV, HBV, and HIV. Clin. Chem. 39:725-726.
15. Vandamme, A. M., S. Van Dooren, W. Kok, P. Goubau, K. Fransen, T. Kievits, J. C. Schmit, E. De Clercq, and J. Desmyter. 1995. Detection of HIV-1 RNA in plasma and serum samples using the NASBA amplification system compared to RNA-PCR. J. Virol. Methods 52:121-132.
16. Van Gemen, B., T. Kievits, R. Schukkink, D. Van Strijp, L. T. Malek, R. Sooknanan, H. G. Huisman, and P. Lens. 1993. Quantification of HIV-1 RNA in plasma using NASBA during a primary HIV-1 infection. J. Virol. Methods 43:177-188.
17. Winters, M. A., L. B. Tan, D. A. Katzenstein, and T. C. Merigan. 1993. Biological variation and quality control of plasma human immunodeficiency virus type 1 RNA quantitation by reverse transcriptase polymerase chain reaction. J. Clin. Microbiol. 31:2960-2966.
18. Yen-Lieberman, B., D. Brambilla, B. Jackson, J. Bremer, R. Coombs, M. Cronin, S. Herman, D. Katzenstein, S. Leung, H. J. Lin, P. Palumbo, S. Rasheed, J. Todd, M. Vahey, and P. Reichelderfer. 1996. Evaluation of a quality assurance program for quantitation of human immunodeficiency virus type 1 RNA in plasma by the AIDS Clinical Trials Group virology laboratories. J. Clin. Microbiol. 34:2695-2701.
19. Yerly, S., L. Kaiser, C. Baumberger, B. Hirschel, and L. H. Perrin. 1995. Early and prolonged decrease of viremia in HIV-1 infected patients treated with didanosine. J. Acquired Immune Defic. Syndr. 8:358-364.